Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,986 | -100,077 | -71,514 | -44,899 | -21,220 |
| Depreciation Amortization | 2,690 | 4,863 | 3,161 | 1,876 | 678 |
| Accounts payable and accrued liabilities | -1,933 | -12,470 | 5,601 | 4,103 | 2,185 |
| Other Working Capital | 4,394 | -37,005 | -9,550 | -3,496 | 5,472 |
| Other Operating Activity | 6,133 | 23,296 | 2,002 | 531 | -320 |
| Operating Cash Flow | $-27,702 | $-121,393 | $-70,300 | $-41,885 | $-13,205 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,972 | -336,341 | -295,279 | -228,531 | -172,145 |
| PPE Investments | -2,913 | -6,529 | -5,173 | -3,454 | -1,246 |
| Sale Of Investment | 59,551 | 130,562 | 88,062 | 38,064 | N/A |
| Investing Cash Flow | $49,666 | $-212,308 | $-212,390 | $-193,921 | $-173,391 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 107,904 | 3,900 | 9,042 | 1,443 | 487 |
| Other Financing Activity | 3,115 | 13,896 | 0 | 0 | 0 |
| Financing Cash Flow | $111,019 | $17,796 | $9,042 | $1,443 | $487 |
| Exchange Rate Effect | -227 | -439 | 363 | 30 | -281 |
| Beginning Cash Position | 69,856 | 386,200 | 386,200 | 386,200 | 386,200 |
| End Cash Position | 202,612 | 69,856 | 112,915 | 151,867 | 199,810 |
| Net Cash Flow | $132,756 | $-316,344 | $-273,285 | $-234,333 | $-186,390 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,702 | -121,393 | -70,300 | -41,885 | -13,205 |
| Capital Expenditure | -2,920 | -6,555 | -5,173 | -3,454 | -1,246 |
| Free Cash Flow | -30,622 | -127,948 | -75,473 | -45,339 | -14,451 |